Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2022 | Potential of immunotherapy for pancreatic cancer

Vinod Balachandran, MD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the potential of immunotherapy in pancreatic cancer. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.